TerrAscend (OTCMKTS:TSNDF) Issues Earnings Results, Misses Expectations By $0.02 EPS

TerrAscend (OTCMKTS:TSNDF) announced its quarterly earnings data on Thursday. The company reported ($0.04) EPS for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.02), Zacks reports. TerrAscend had a negative return on equity of 23.19% and a negative net margin of 40.86%.

TerrAscend Price Performance

Shares of TSNDF opened at $0.59 on Friday. The company has a 50 day moving average of $0.81 and a 200-day moving average of $0.57. The company has a quick ratio of 1.07, a current ratio of 1.45 and a debt-to-equity ratio of 1.94. TerrAscend has a twelve month low of $0.23 and a twelve month high of $1.25. The stock has a market capitalization of $180.74 million, a P/E ratio of -1.44 and a beta of 1.45.

Analyst Upgrades and Downgrades

Separately, Canaccord Genuity Group raised shares of TerrAscend to a “strong-buy” rating in a research note on Thursday, October 9th. Two analysts have rated the stock with a Strong Buy rating, According to MarketBeat.com, the company currently has an average rating of “Strong Buy”.

About TerrAscend

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names.